Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong · Delayed Price · Currency is HKD 81.20
-0.70 (-0.85%)
Sep 10, 2026, 4:08 PM HKT
Vigonvita Life Sciences Revenue
Vigonvita Life Sciences had revenue of 65.89M CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 217.26M. In the year 2025, Vigonvita Life Sciences had annual revenue of 102.10M with 762.88% growth.
Revenue (ttm)
217.26M CNY
Revenue Growth
+762.88%
P/S Ratio
54.26
Revenue / Employee
618.98K CNY
Employees
351
Market Cap
13.61B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.10M | 90.26M | 762.88% |
| Dec 31, 2024 | 11.83M | -187.82M | -94.07% |
| Dec 31, 2023 | 199.65M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.